Drug offers leukaemia sufferers new hope
Until now the survival rate for people with a form of leukaemia called Chronic Myeloid Leukaemia (CML) was around five years.
The availability of the Cork-made cancer medicine means that people with the disease can get on with their lives.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.



